| Health / Medical Topics |
Caracemide
An agent derived from acetohydroxamic acid with potential antineoplastic activity. Caracemide inhibits ribonuclease reductase, resulting in decreased DNA synthesis and tumor growth; it also inhibits acetylcholinesterase. In vivo, caracemide contributes to the formation of the neurotoxin methyl isocyanate; this effect, along with the agent's acetylcholinesterase activity, may be responsible for the severe central nervous system toxicity observed in clinical trials. (NCI Thesaurus)
YOU MAY ALSO LIKE
A drug used to treat cancers of the breast, colon, rectum, stomach, and pancreas. Under the brand names Carac, Tolak, Efudex, and…
A type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so…
A journey in an automobile.
A special receptor created in the laboratory that is designed to bind to certain proteins on cancer cells. The CAR is then…
A diffuse swelling of the scalp in a newborn, usually caused by the trauma of the scalp pushing through a narrowed cervix…
Issue associated with the inability of device and/or device components to achieve successful depolarization and contraction of a cardiac chamber caused by…
